<DOC>
	<DOCNO>NCT00742157</DOCNO>
	<brief_summary>Treatment 3.5-8 week GH ( 0.05 mg/kg/day ) +GLN+Diet , follow continue compliance individualized oral diet enteral GLN , result reduce volume TPN infusion/week and/or reduce frequency TPN infusions/week .</brief_summary>
	<brief_title>Evaluate Efficacy Safety Growth Hormone , Glutamine Diet Patients With Short Bowel Syndrome ( SBS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Be male female 19 78 year age , inclusive Have diagnosis SBS 1 follow characteristic : Dependent upon TPN and/or IV fluid Unable receive TPN document history complication associate longterm parenteral infusion ( e.g . lack venous access , multiple septic event , progressive liver dysfunction TPN , etc ) A document remnant bowel anatomy inconsistent adequately support life without parenteral support ( e.g . &lt; 70 cm healthy small intestine portion colon , less 150 cm patient colon ) A documented history diarrhea and/or malabsorption significantly compromise patient 's nutritional hydration status ( e.g . significant weight loss 5 % 1 month 10 % 6 month , serum albumin &lt; 3.5 g/dl , document nutrient deficiency , document episodes dehydration , etc ) . Is able eat least ( &gt; 500 calorie ) solid food regular basis tolerate least ( &gt; 500 calorie ) enteral feed formula Have stable liver renal function For patient know hypertension cardiovascular disorder , compensate stabilized regular therapeutic regimen For woman participate study , manifest give assent 1 follow criterion ensure patient become pregnant study : The patient must surgically sterile demonstrably postmenopausal . Any patient capable become pregnant must negative urine pregnancy test must agree practice method contraception document least 90 % reliability throughout treatment period . Have ability understand requirement study , provide write Informed Consent , abide study restriction agree complete require assessment Followup Period Be pregnant lactate Have history mental deficiency illness might compromise compliance requirement study Have clinically serious neurological dysfunction Have hypoxemic pulmonary disease ( i.e. , rest pAO2 &lt; 75 torr ) Have unstable ischemic heart disease uncompensated cardiac failure Have participate study involve investigation drug within 30 day prior entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Growth Hormone</keyword>
	<keyword>TPN</keyword>
	<keyword>Total Parenteral Nutrition</keyword>
	<keyword>Glutamine</keyword>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>Increase absorption small bowel .</keyword>
</DOC>